Halozyme

Read more
Helen Torley's photo - President & CEO of Halozyme

President & CEO

Helen Torley

CEO Approval Rating

87/100

Founded:

1998

Status:

PublicIndependent CompanyNASDAQHALO

Annual Revenue
Employees
Sector

- -

HALOZYME TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Amphastar Pharmaceuticals is seen as one of Halozyme's top competitors. Amphastar Pharmaceuticals's headquarters is in Rancho Cucamonga, California, and was founded in 1996. Amphastar Pharmaceuticals competes in the Pharmaceuticals industry. Amphastar Pharmaceuticals generates 111% of Halozyme's revenue.

Pacira is one of Halozyme's top rivals. Pacira was founded in 2006, and its headquarters is in Parsippany, New Jersey. Pacira competes in the Pharmaceuticals field. Pacira has 343 more employees than Halozyme.

Xenetic is Halozyme's #3 rival. Xenetic is a Public company that was founded in 2011 in Framingham, Massachusetts. Xenetic operates in the Medical Research & Laboratories industry. Compared to Halozyme, Xenetic has 277 fewer employees.

Halozyme Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$331.3M

Halozyme's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 6.8B. Over the last four quarters, Halozyme's revenue has grown by 61.2%. Specifically, in Q1 2021's revenue was $89M; in Q4 2020, it was $121.7M; in Q3 2020, it was $65.3M; in Q2 2020, Halozyme's revenue was $55.2M.

Halozyme Acquisitions

No recent acquisitions found related to Halozyme

Halozyme Funding History

Since Halozyme was founded in 1998, it has participated in 2 rounds of funding. In total Halozyme has raised $150.0M. Halozyme's last funding round was on Jan 2016 for a total of $150.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jan 2016
$150M

Pharmakon Advisors

IPO
May 2013
--

Since Halozyme was founded in 1998, it has participated in 2 rounds of funding. In total Halozyme has raised $150.0M. Halozyme's last funding round was on Jan 2016 for a total of $150.0M

Halozyme Investments

No recent investments found related to Halozyme

Halozyme News

Halozyme Press Releases

Halozyme Videos

Social Media

Halozyme Headquarters

11388 Sorrento Valley Road

San Diego, California92121

1-858-794-8889

Driving Directions »

Trending Companies

Halozyme Summary

ABOUT

Overview

Halozyme develops and commercializes pharmaceutical products for the endocrinology, oncology and dermatology. Halozyme was founded in 1998. Halozyme's headquarters is located in San Diego, California, USA 92121. It has raised 150.0M in 2 rounds. The l...

CEO

Halozyme's President & CEO, Helen Torley, currently has an approval rating of 87%. Halozyme's primary competitors are Amphastar Pharmaceuticals, Pacira & Xenetic.

Frequently Asked Questions about Halozyme

  1. When was Halozyme founded?

    Halozyme was founded in 1998
  2. Who is Halozyme's CEO?

    Halozyme's CEO is Helen Torley
  3. How much revenue does Halozyme generate?

    Halozyme generates $331.3M in revenue
  4. How much funding does Halozyme have?

    Halozyme has historically raised $150M in funding
  1. Where is Halozyme's headquarters?

    Halozyme's headquarters is in San Diego California, USA
  2. How many employees does Halozyme have?

    Halozyme has 281 employees
  3. Who are Halozyme's competitors?

    Halozyme's top competitors are Amphastar Pharmaceuticals, Pacira, Xenetic